Aurora Cannabis ACB shares are trading higher on Tuesday in anticipation of the company's fourth-quarter earnings results, which are scheduled after the close today.
On Monday, Jefferies upgraded Aurora from Underperform to Hold and cut his price target from $10.51 to $6.53.
See Also: Jefferies Upgrades Aurora And Tilray, Says Valuations, Estimates 'Now More Realistic'
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis shares were trading up 17% at $7.40 on Tuesday at the time of publication. The stock has a 52-week high of $62.88 and a 52-week low of $5.30.
Update: Aurora Cannabis Stock Plunges 18% After Q4 Earnings Call
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
